BZgA meets PEI: Dr Heidrun Thaiss visits the Paul-Ehrlich-Institut
On 11 December 2018, Dr Heidrun Thaiss, head of the Bundeszentrale für gesundheitliche Aufklärung (BZgA, Federal Centre for Health Education) was visiting the Paul-Ehrlich-Institut for talks on a more intensive co-operation. One of the important subjects that concern both institutes is improving vaccination protection of the population. Both institutes contribute to this aim in different ways.
Supply shortage of influenza vaccines - Information for wholesalers and pharmacists for the implementation of the notice under § 79 (5) AMG
The Federal Ministry of Health recently found a supply shortage for influenza vaccines (§ 79 Abs. 5 AMG). If you have legal questions regarding the purchase of influenza vaccines from abroad, please contact your local state authority directly. The Paul-Ehrlich-Institut will gladly answer your questions about the status of the batch release of flu vaccine batches sent to Germany from other EU countries.
Isabelle Bekeredjian-Ding elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI)
On 9 November 2018, the IMI Scientific Committee elected Professor Isabelle Bekeredjian-Ding, head of Division Microbiology at the Paul-Ehrlich-Institut (PEI) as its chair for a period of two years. The primary purpose of IMI is to provide access to innovative medicines for people in Europe, including the increasing number of elderly people, and to support the development of such medicines.